- Home
- MNPR vs JILL Comparison
MNPR vs JILL Comparison
Compare MNPR & JILL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- JILL
- Stock Information
- Founded
- MNPR 2014
- JILL 1959
- Country
- MNPR United States
- JILL United States
- Employees
- MNPR N/A
- JILL N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- JILL Clothing/Shoe/Accessory Stores
- Sector
- MNPR Health Care
- JILL Consumer Discretionary
- Exchange
- MNPR Nasdaq
- JILL Nasdaq
- Market Cap
- MNPR 248.8M
- JILL 233.1M
- IPO Year
- MNPR 2019
- JILL 2017
- Fundamental
- Price
- MNPR $66.64
- JILL $18.09
- Analyst Decision
- MNPR Strong Buy
- JILL Buy
- Analyst Count
- MNPR 11
- JILL 3
- Target Price
- MNPR $68.60
- JILL $18.00
- AVG Volume (30 Days)
- MNPR 44.1K
- JILL 106.6K
- Earning Date
- MNPR 11-07-2025
- JILL 09-03-2025
- Dividend Yield
- MNPR N/A
- JILL 1.76%
- EPS Growth
- MNPR N/A
- JILL N/A
- EPS
- MNPR N/A
- JILL 2.39
- Revenue
- MNPR N/A
- JILL $601,713,000.00
- Revenue This Year
- MNPR N/A
- JILL $1.37
- Revenue Next Year
- MNPR N/A
- JILL $1.94
- P/E Ratio
- MNPR N/A
- JILL $7.61
- Revenue Growth
- MNPR N/A
- JILL N/A
- 52 Week Low
- MNPR $3.90
- JILL $13.36
- 52 Week High
- MNPR $68.18
- JILL $30.40
- Technical
- Relative Strength Index (RSI)
- MNPR 80.24
- JILL 60.32
- Support Level
- MNPR $42.51
- JILL $17.52
- Resistance Level
- MNPR $45.78
- JILL $18.51
- Average True Range (ATR)
- MNPR 4.36
- JILL 0.79
- MACD
- MNPR 2.91
- JILL 0.04
- Stochastic Oscillator
- MNPR 95.65
- JILL 81.89
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About JILL J. Jill Inc.
J.Jill Inc is a national lifestyle brand that provides apparel, footwear, and accessories. The company's products are marketed under the J.Jill brand name and sold through its two channels: its e-commerce platform and catalog (Direct) and its retail stores (Retail). Revenue is derived from the sale of apparel and accessory merchandise through the company's Retail and Direct channels, which include website and catalog phone orders. Revenue also includes shipping and handling fees collected from customers.